Roche Venture Fund Overview
- Investor Type
-
Venture Capital
- Status
-
Active
- Professionals
-
5
- Investments
-
169
- Portfolio
-
24
- Exits
-
104
Roche Venture Fund General Information
Company Description
Founded in 2002, Roche Venture Fund is the corporate venture capital arm of Roche Holding based in Basel, Switzerland. The firm prefers to make investments in early-stage life science companies operating in the pharmaceuticals and diagnostics sectors.
Business Details
Website
venturefund.roche.comYear Founded
Investor Status
Primary Investor Type
Corporate Office
- Grenzacherstrasse 124
- 4070 Basel
- Switzerland
Roche Venture Fund Investments (169)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| Forcefield Therapeutics | 28-Mar-2024 | Early Stage VC | Drug Discovery | Generating Revenue | ||
| Mission Therapeutics | 11-Mar-2024 | Drug Discovery | Clinical Trials - Phase 2 | |||
| Freenome | 15-Feb-2024 | Decision/Risk Analysis | Clinical Trials - General | |||
| Cour | 30-Jan-2024 | Drug Discovery | Clinical Trials - Phase 2 | |||
| GlycoEra | 08-Jan-2024 | Biotechnology | Pre-Clinical Trials | |||
| NMD Pharma | 15-Nov-2023 | Biotechnology | Clinical Trials - Phase 2 | |||
| Mironid | 13-Sep-2023 | Therapeutic Devices | Generating Revenue | |||
| Diogenx | 01-Mar-2023 | Drug Discovery | Generating Revenue | |||
| Bonum Therapeutics | 15-Nov-2022 | Early Stage VC | Drug Discovery | Generating Revenue | ||
| Thelium Therapeutics | 20-Apr-2022 | Seed Round | Pharmaceuticals | Out of Business |
Roche Venture Fund Exits (104)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| Nimble Therapeutics | 23-Jan-2025 | Merger/Acquisition | |
| Syapse | 30-Dec-2024 | ||
| Arch Oncology | 31-May-2024 | ||
| Enliven Therapeutics | 23-Feb-2023 | ||
| Lino Biotech | 22-Feb-2023 | ||
| Thelium Therapeutics | 06-Jan-2023 | ||
| Purigen Biosystems | 30-Nov-2022 | ||
| Good Therapeutics | 18-Aug-2022 | ||
| MacuLogix | 26-Jul-2022 | Merger/Acquisition | |
| BlueLight Therapeutics | 04-Nov-2021 | Out of Business |
Roche Venture Fund Investments by Industry, Year, and Region
Investments by Industry
Investments by Year
Investments by Region
Roche Venture Fund Co-Investors (121)
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| Sofinnova Partners | 4 |
|
|
||
| 503 Partners |
|
|
|||
| 5AM Ventures |
|
|
|||
| American Century Investments |
|
|
|||
| RiverVest Venture Partners |
|
|
Roche Venture Fund FAQs
-
What is Roche Venture Fund?
Founded in 2002, Roche Venture Fund is the corporate venture capital arm of Roche Holding based in Basel, Switzerland.
-
When was Roche Venture Fund founded?
Roche Venture Fund was founded in 2002.
-
Where is Roche Venture Fund headquartered?
Roche Venture Fund is headquartered in Basel, Switzerland.
-
What is Roche Venture Fund's total asset value?
Roche Venture Fund has around in total assets under management.
-
How many investments has Roche Venture Fund made?
Roche Venture Fund has made 169 investments.
-
What has Roche Venture Fund invested in?
Roche Venture Fund has made numerous investments in companies like Forcefield Therapeutics, Mission Therapeutics, and Freenome within the Drug Discovery and Decision/Risk Analysis industries.
-
What has Roche Venture Fund invested in recently?
Roche Venture Fund's latest investment was on 28-Mar-2024 in Forcefield Therapeutics, a company within the Drug Discovery industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
